Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) today announced that it is
scheduled to make an investor presentation at the UBS Global Specialty
and Generic Pharmaceuticals Conference. David Seltzer, President and
Chief Executive Officer, will deliver the Company's presentation on
Wednesday, May 28, 2008, at 3:00 p.m. London Time. The conference is
being held May 28 - 29, 2008, at The Waldorf Hilton, London, England.
A live audio webcast of the Company's presentation can be accessed on
the Company’s website:
http://www.hitechpharm.com
The webcast will be archived within 24 hours after the live event and
will be available for four weeks following the conference.
About Hi-Tech Pharmacal
Hi-Tech Pharmacal is a specialty pharmaceutical company developing,
manufacturing and marketing generic and branded products. The Company
specializes in difficult to manufacture liquid and semi-solid dosage
forms and produces a range of sterile ophthalmic, otic and inhalation
products. The Company’s Health Care Products
Division is a leading developer and marketer of branded prescription and
OTC products for the diabetes marketplace.
Forward-looking statements (statements which are not historical facts)
in this Press Release are made pursuant to the safe harbor provisions of
the Private Securities Litigation Reform Act of 1995. Forward-looking
statements are not promises or guarantees and investors are cautioned
that all forward-looking statements involve risks and uncertainties,
including but not limited to the impact of competitive products and
pricing, product demand and market acceptance, new product development,
the regulatory environment, including without limitation, reliance on
key strategic alliances, availability of raw materials, fluctuations in
operating results and other results and other risks detailed from time
to time in the Company's filings with the Securities and Exchange
Commission. These statements are based on management's current
expectations and are naturally subject to uncertainty and changes in
circumstances. We caution you not to place undue reliance upon any such
forward looking statements which speak only as of the date made. Hi-Tech
is under no obligation to, and expressly disclaims any such obligation
to, update or alter its forward-looking statements, whether as a result
of new information, future events or otherwise.
Hi-Tech Pharmacal Co., Inc.
Bill Peters, 631-789-8228
